<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 28-year-old Japanese woman with suspected <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythemia</z:e> (ET) had marked <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo>, mild <z:hpo ids='HP_0001974'>leukocytosis</z:hpo> with <z:mpath ids='MPATH_458'>normal</z:mpath> neutrophil alkaline phosphatase activity, and no <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>She was monitored without being given any medication </plain></SENT>
<SENT sid="2" pm="."><plain>Eleven years later, complete blood counts showed no remarkable changes but some non-lobulated mononuclear megakaryocytes were found in the bone marrow </plain></SENT>
<SENT sid="3" pm="."><plain>Cytogenetic analysis revealed deletion of the long arm of chromosome 5 (5q-) </plain></SENT>
<SENT sid="4" pm="."><plain>Subsequently, <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> and platelet counts decreased gradually, <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> appeared and progressed, after which <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> developed </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002488'>Acute leukemia</z:hpo> developed 16 years after the first documentation of <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e> is known to be a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with unique clinical features and cases with this syndrome presenting with <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo> of more than 1,000 x 10(9)/L but without <z:hpo ids='HP_0001903'>anemia</z:hpo> are rare </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, it is noteworthy that in this patient transition to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> occurred following development of <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> and marked <z:hpo ids='HP_0001744'>splenomegaly</z:hpo>, which are generally observed in blastic crises resulting from <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e>) </plain></SENT>
<SENT sid="8" pm="."><plain>The patient showed features indicative of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e> rather than of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in spite of presenting with 5q- chromosomal abnormality </plain></SENT>
<SENT sid="9" pm="."><plain>This case supports the concept of "mixed myelodysplastic and myeloproliferative syndromes" and suggests the possibility of the appearance of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e>-like manifestations in <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e> </plain></SENT>
</text></document>